Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2008 · first_quarter · 1A
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2008 · first_quarter · Q1
Source: Senate LDA
HR 2606 and S 1376 Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs Protecting 340B Drug Pricing Program
HR 2606 and S 1376 Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs Protecting 340B Drug Pricing Program
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
HR 2606 and S 1376 Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs Protecting 340B Drug Pricing Program
HR 2606 and S 1376 Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs Protecting 340B Drug Pricing Program
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Progam, the Medicare Modernization Act of 2003, the Deficit Reducation Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R. 2606).
16. Specific Lobbying Issues: Proposed guidelines from the Health Resources & Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R 2606),
Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Progam, the Medicare Modernization Act of 2003, the Deficit Reducation Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R. 2606).
16. Specific Lobbying Issues: Proposed guidelines from the Health Resources & Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R 2606),
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2008 · third_quarter · RA
HR 2606 and S 1376 Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs Protecting 340B Drug Pricing Program
HR 2606 and S 1376 Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs Protecting 340B Drug Pricing Program
2008 · first_quarter · Q1
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2007 · year_end · YY
Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Progam, the Medicare Modernization Act of 2003, the Deficit Reducation Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R. 2606).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2007 · mid_year · MM
16. Specific Lobbying Issues: Proposed guidelines from the Health Resources & Services Administration (HRSA) addressing the definition of "patient" under the 340B Drug Discount Program, FY2008 Labor Health & Human Services & Education Appropriations addressing funding for the Office of Pharmacy Affairs (HRSA). Section 340B of the Public Health Service Act and issues related to the implementation of the 340B Drug Discount Program, the Medicare Modernization Act of 2003, the Deficit Reduction Act of 2005 as it pertains to the addition of Children's Hospitals to the 340B Program, physician administered drugs, nominal pricing, the redefining of average manufacturer price (AMP), 340B Program Improvement & Integrity Act of 2007 (S. 1376/H.R 2606),
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2007 · mid_year · RR
2007 · mid_year · RR
2007 · mid_year · RR